GMIM
HAE icon

General Motors Investment Management’s Haemonetics HAE Stock Holding History

General Motors Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,100
Closed -$409K – 279
2015
Q1 		$409K Hold
9,100
– – 0.04% 573
2014
Q4 		$341K Hold
9,100
– – 0.03% 640
2014
Q3 		$318K Hold
9,100
– – 0.03% 648
2014
Q2 		$321K Buy
+9,100
New +$304K 0.03% 653

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

General Motors Investment Management's HAE Position: Q2 2015 in Review

General Motors Investment Management sold out of Haemonetics (HAE) in Q2 2015, closing a stake of 9,100 shares — an estimated $409K sold.

General Motors Investment Management first reported a position in HAE in Q2 2014 and held it in 4 quarters. The position peaked at $409K in Q1 2015. 181 funds tracked by Wall St. Rank hold HAE as of Q2 2015.

  • General Motors Investment Management reported no remaining Haemonetics position as of Q2 2015 after selling out during the quarter.
  • General Motors Investment Management sold 9,100 Haemonetics shares in Q2 2015, an estimated $409K.
  • General Motors Investment Management first reported a position in Haemonetics in Q2 2014 and held it in 4 quarters.
  • General Motors Investment Management's Haemonetics position peaked at $409K in Q1 2015.
  • 181 funds tracked by Wall St. Rank held Haemonetics as of Q2 2015.

Based on General Motors Investment Management's 13F filing for Q2 2015, filed 5 Aug 2015.